Skip to content
Logo text: ISPOR Improving healthcare decisions

Health Technology Assessment Central

The HTA Resource Center for Informing Healthcare Decisions

  • Home
  • What Is HTA?
  • HTA News and Events
  • Resource Library
  • Governance
  • Policy Interchange
  • Training and Development
« Back to ISPOR.org

News

Health technology assessments receive European Parliament backing

November 3, 2018

https://www.medicalplasticsnews.com/news/european-parliament-backs-health-technology-assessments/

Posted in: Uncategorized

Post navigation

← European Parliament further clarifies Commission proposal on HTA for medical technologies
New EU law to inform medicine pricing →

News

INAHTA welcomes NICE, UK as newest member
INAHTA welcomes SEC, Ukraine, as Candidate Member
HIQA signs memorandum of understanding to support health technology assessment in Ireland, Scotland and Wales
Growing Patient Involvement in Health Technology Assessment (HTA)
NICE launches online resource to help development and adoption of new health technologies
CADTH Celebrates Health Technology Assessment Leaders
Canada to create national drug agency to help cut cost of medicines
Bermuda Health Council Accepted Into RedETSA
Health Canada & HTA Body CADTH To Offer Parallel Scientific Advice
UHC Act: The role of Health Technology

Twitter

Tweets about #HTA

#HTA

HenryJOncologyDr Henry@HenryJOncology·
26m

@mghdiabetessupp @RebeccaSlatkin @shanselman @Walmart @WalmartInc @isaac2004 @CADTH_ACMTS Love the #stayinyourlane reference. I do know a thing or two about evidence, and I can assure you that a meta-analysis and full #HTA in 2010 (which includes real clin experts) trumps a review article from 2003.

Please share some real evidence to make your point.

Reply on Twitter 1163258600321703936Retweet on Twitter 1163258600321703936Like on Twitter 1163258600321703936Twitter 1163258600321703936
HenryJOncologyDr Henry@HenryJOncology·
1h

@isaac2004 @shanselman @Walmart @WalmartInc Ha! No worries. I am not a diabetes expert and respect the opinions of others, especially patients. Just reflecting on my own experience as a resident in 2011 in Alberta.

The basic of T1DM, needing insulin, remains the same. Will post the #HTA on the analogues for reference

Reply on Twitter 1163248223542267904Retweet on Twitter 1163248223542267904Like on Twitter 1163248223542267904Twitter 1163248223542267904
MonaJM3Mouna Jameleddine@MonaJM3·
17 Aug

Glad that our abstract "Trastuzumab for early and locally advanced HER2 positive breast cancer : #INEAS_Tunisia #HTA report" is accepted to be presented @ISPORorg Europe 2019

#towards an evidence based decision making in Tunisia

Reply on Twitter 1162697089886883840Retweet on Twitter 1162697089886883840Like on Twitter 11626970898868838401Twitter 1162697089886883840
Load More...
Privacy Policy | Disclaimer
Copyright © 2019 ISPOR – The Professional Society for Health Economics and Outcomes Research